SGLT2 inhibitors for patients with type 2 diabetes mellitus after myocardial infarction: a nationwide observation registry study from SWEDEHEARTResearch in context

• 主要な著者: Hans Christian Rosén (著者), Moman A. Mohammad (著者), Tomas Jernberg (著者), Stefan James (著者), Jonas Oldgren (著者), David Erlinge (著者)
• フォーマット: 図書
• 出版事項: Elsevier, 2024-10-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Summary: Background: Sodium-glucose co-transporter 2 (SGLT2) inhibitors have been shown to reduce rates of heart failure hospitalisations and cardiovascular death in patients with type 2 diabetes and prior cardiovascular disease. We hypothesised that SGLT2 inhibitors could provide cardiovascular ben...